• Slide title

    With our globally acclaimed expertise in bioanalysis (non-GLP, GLP, GCP), CNS, DMPK, oncology, immunology, respiratory and toxicology (non-GLP/GLP) we bring a transformative approach to your projects. 



    Release the potential of your research journey with Pharmidex as your premier partner in drug discovery.

    Button

  • Slide title

    Empower your research programmes with Pharmidex, a leading Contract Research Organisation (CRO), offering cutting-edge translational solutions. 



    With our globally acclaimed expertise in bioanalysis (non-GLP, GLP, GCP), CNS, DMPK, oncology, immunology, respiratory and toxicology (non-GLP/GLP) we bring a transformative approach to your projects. 

    Button

Service Offerings

Therapeutic Areas

Services By Developmental Phase

Latest News

Who We Are

About us

Pharmidex is a contract research organisation (CRO) that provides translational solutions using its world-renowned expertise in CNS, oncology, respiratory, DMPK, drug discovery and ADMET/pharmacokinetics.


Founded in the UK, in 2002, Pharmidex operates in state-of-the-art facilities in Hertfordshire to provide high-quality experimental data and expert guidance to support drug discovery and development.

Key Facts

Experts in therapeutic preclinical models 


Accredited by AAALAC and the MHRA to perform GLP and GCP certified services

Services

Single site service offering with 15,000+ studies conducted to date


Quick turnaround times, cost effective research, expert interpretation and customer-focused approach

Our History

Successfully helped multiple clients reach clinical development since 2002

News

DMPK Services News!

🌟 Pharmidex Announcement 🌟

November 19, 2024
We are delighted to announce that Ian Knowles , our Head of Respiratory, will represent Pharmidex at the 7th Annual Inhalation & Respiratory Drug Delivery Conference and Christmas Industry Celebration! 🎄💨 📅 Dates: November 21-22, 2024 📍 Venue: Occidental Praha, Prague, Czechia Ian is looking forward to engaging with all attendees, sharing insights, and exploring the latest innovations in respiratory and inhalation drug delivery. Events like these are a fantastic opportunity to foster collaboration, advance research, and shape the future of respiratory medicine. If you’re attending, be sure to connect with Ian at the event, he’d be thrilled to meet and discuss ideas with you!

🚀 Pharmidex Advances Neurodegenerative Research! 🚀

November 18, 2024
We’re excited to join the "Quest for New Medicines to Slow Disability in Neurodegenerative Disorders" this November! Meet Prof. Mo Alavijeh , Stephen Mitchell , Jewel Ahmed and Janette Dalay Robertson , who are eager to discuss cutting-edge developments and collaborative opportunities in neurodegenerative research. If you're attending, let's connect and explore how Pharmidex can accelerate your research!

🌟 Pharmidex at Medicine at the Crick | New Frontiers in Drug Discovery 🌟

November 18, 2024
We are excited to announce that Pharmidex will be participating in the Medicine at the Crick | New Frontiers in Drug Discovery meeting! Our Head of Operations, Ash Alavijeh , will be representing Pharmidex at this prestigious event. Ash is looking forward to connecting with fellow attendees, discussing the latest breakthroughs in drug discovery, and exploring opportunities for collaboration. This meeting is a fantastic platform for exchanging ideas and advancing innovation in medicine come meet us and learn how Pharmidex’s expertise in preclinical research can support your drug discovery journey! 📅 When: 18/11/2024 📍 Where: Francis Crick Institute We can’t wait to see you there!
Services by Department
Share by: